ABC: Heart Failure & Cardiomyopathy最新文献

筛选
英文 中文
Myocarditis: a Whole Heart Involvement Revealed by Cardiac Magnetic Resonance Mapping. A Case-control Study 心肌炎:心脏磁共振成像显示的全心累及。病例对照研究
ABC: Heart Failure & Cardiomyopathy Pub Date : 2021-02-04 DOI: 10.21203/RS.3.RS-174912/V1
T. Pereira, M. Balk, Gabriela Bartzen Pereira, Victoria Ramos, L. Giordani, P. Schvartzman, L. Beck-da-Silva
{"title":"Myocarditis: a Whole Heart Involvement Revealed by Cardiac Magnetic Resonance Mapping. A Case-control Study","authors":"T. Pereira, M. Balk, Gabriela Bartzen Pereira, Victoria Ramos, L. Giordani, P. Schvartzman, L. Beck-da-Silva","doi":"10.21203/RS.3.RS-174912/V1","DOIUrl":"https://doi.org/10.21203/RS.3.RS-174912/V1","url":null,"abstract":"\u0000 Purpose: To ascertain if differences in T1 and T2 mapping exist between ventricular wall segments with and without late gadolinium enhancement (LGE) in patients with myocarditis, and to compare these findings to those of control subjects.Methods: In a case-control design, 22 patients with Cardiac Magnetic Resonance (CMR) evidence of myocarditis and 18 controls with normal CMR were assessed. The workup included: (1) T1 mapping (ShMOLLI); (2) LGE; (3) T2 mapping (SSFP); and (4) the T2 signal intensity of the myocardium divided by that of skeletal muscle (T2 ratio). T1 and T2 mapping of affected (LGE+) and unaffected (LGE-) ventricular segments of cases were compared, as were those of controls versus cases.Results: On within-group comparison, ventricular segments with evidence of late enhancement (LGE+) in cases showed a mean T1 value significantly different from that of unaffected (LGE-) ventricular walls (1057±30 vs. 1028±48; p=0.0001). On between-group comparison, the mean T1 value of LGE- segments in cases was significantly different from the mean of the corresponding walls in controls (1028±48 vs. 996±10; p<0.0001). The mean T2 maps of LGE- walls in cases were not statistically different from those of controls (49±4 vs. 49±1; p=0.9229).Conclusions: This case-control study suggests that T1 mapping demonstrates significant alterations in the myocardium of patients with myocarditis even in the absence of late gadolinium enhancement. Specifically, T1 mapping revealed diffuse myocardial involvement not evidenced by LGE imaging. T2 mapping was noncontributory.","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127766366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Evaluation and Perioperative Complications in Patients with Cancer and Ventricular Dysfunction 肿瘤合并心室功能障碍患者的术前评价及围手术期并发症
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20220094
A. Issa, G. Zagni, Vithoria Vidotti, T. F. Guimarães, Milena Santos, C. M. P. Silva
{"title":"Preoperative Evaluation and Perioperative Complications in Patients with Cancer and Ventricular Dysfunction","authors":"A. Issa, G. Zagni, Vithoria Vidotti, T. F. Guimarães, Milena Santos, C. M. P. Silva","doi":"10.36660/abchf.20220094","DOIUrl":"https://doi.org/10.36660/abchf.20220094","url":null,"abstract":"During cancer treatment, surgery may be indicated for patients with diverse purposes, such as diagnosis, staging, oncologic cure, palliative treatment, support","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122544943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventricular Dysfunction and Heart Failure in Patients Undergoing Hematopoietic Stem Cell Transplant 造血干细胞移植患者的心室功能障碍和心力衰竭
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20220090
K. Luz, Beatriz da Silva Costa Cortizo, M. Moreira
{"title":"Ventricular Dysfunction and Heart Failure in Patients Undergoing Hematopoietic Stem Cell Transplant","authors":"K. Luz, Beatriz da Silva Costa Cortizo, M. Moreira","doi":"10.36660/abchf.20220090","DOIUrl":"https://doi.org/10.36660/abchf.20220090","url":null,"abstract":"It has been known for a long time that Cyclophosphamide (Cy) for conditioning regimens in hematopoietic stem cell transplant (HSCT) can induce cardiotoxicity. 1 We have been learning in cardio-oncology that the best practice is to identify the risks of cardiotoxicity and, when possible, minimize them before the exposure. Several factors contribute to define cardiovascular toxicity risks including the type of transplant, age at transplant, hypertension, diabetes mellitus, dyslipidemia, and current smoking. Multiple uncontrolled preexisting cardiovascular conditions such as atrial fibrillation or atrial flutter, node sinus disease, ventricular arrhythmias, coronary artery disease, valve diseases and heart failure with reduced ejection fraction may also contribute to cardiotoxicity. So, it is important to know about the disease severity at the time of transplantation and probability of relapse, which may be correlated with increased exposure to other cardiotoxic chemotherapy drugs and radiotherapy before HSCT. There are","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125969010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-T Cells Therapy: What Cardiovascular Adverse Effects Should We Expect? CAR-T细胞治疗:我们应该期待哪些心血管不良反应?
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20230002
W. Martins, Roberto José Pessoa de Magalhães, Tatiana de Fátima Gonçalves Galvão
{"title":"CAR-T Cells Therapy: What Cardiovascular Adverse Effects Should We Expect?","authors":"W. Martins, Roberto José Pessoa de Magalhães, Tatiana de Fátima Gonçalves Galvão","doi":"10.36660/abchf.20230002","DOIUrl":"https://doi.org/10.36660/abchf.20230002","url":null,"abstract":"Immunotherapy has emerged as a specific treatment, guided by oncologic targets, that has given the false impression (to oncologists and hematologists) that it had no adverse effects, including cardiovascular complications. Chimeric antigen receptor (CAR) T-cell therapy has certainly benefited specific patients; in contrast, reports of adverse cardiovascular effects have emerged. In this paper, we conducted a narrative review of conceptual aspects, clinical applicability, the cytokine release syndrome, extracardiac AE and, above all, the cardiovascular AE of CAR-T cell therapy. CAR-T cell therapy has been approved by regulatory agencies in the United States, Europe and Brazil, initially for the treatment of hematological malignancies at advanced stages, after failure or refractoriness. Among extracardiac AE, cytokine release syndrome and, consequently, encephalopathy, macrophage activation syndrome or hemophagocytic lymphohistiocytosis stand out. The most frequently described cardiovascular AE are cardiomyopathies, myocarditis and ventricular dysfunction; tachyarrhythmias, changes in QT and other electrocardiographic changes; pleural and pericardial disease, and changes in biomarkers. Thus, prior to the therapy, it is recommended to perform clinical evaluation, electrocardiogram, echocardiogram, and troponin and B-type natriuretic peptide measurements. The patient should be monitored during treatment with continuous electrocardiogram, serial echocardiogram, and biomarkers. Patients with severe cardiovascular AE should be admitted to a cardiac intensive care unit.","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"91 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127151106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brazilian Scientific Production about Cardiomyopathies: A Review from 2010 to 2022 巴西关于心肌病的科学生产:2010年至2022年的回顾
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20230043
Even Edilce Mol, Sarah Fagundes Grobe, L. Rohde, Lídia Ana Zytynski Moura
{"title":"Brazilian Scientific Production about Cardiomyopathies: A Review from 2010 to 2022","authors":"Even Edilce Mol, Sarah Fagundes Grobe, L. Rohde, Lídia Ana Zytynski Moura","doi":"10.36660/abchf.20230043","DOIUrl":"https://doi.org/10.36660/abchf.20230043","url":null,"abstract":"CM constitute a very heterogeneous group of heart diseases and are one of the leading causes of death either from end-stage heart failure or sudden death due to arrythmias.3 According to the phenotype, CM may be classified into hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and left ventricular noncompaction,1 where there may overlap of phenotypes.4 Each phenotype is then subclassified into: genetic origin (familial), non-genetic (nonfamilial), and mixed, with the genetic form accounting for most of the cases.4 According to the statement of American College of Medical Genetics and Genomics, of the 59 genes mentioned in the document, 30 (51%) had cardiovascular phenotypes, and 16 (27%) included CM phenotypes.5 Non-genetic CM may be caused by infections, autoimmune diseases, and endogenous or exogenous myocardial toxicity, whereas genetic CM may be caused by a variety of known mutations and others under study.6","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126529796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asymptomatic Ventricular Dysfunction and HFrEF Secondary to Classic Chemotherapy 经典化疗继发的无症状脑室功能障碍和HFrEF
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20220078
M. Avila, D. Belfort, S. Martins, L. Hajjar
{"title":"Asymptomatic Ventricular Dysfunction and HFrEF Secondary to Classic Chemotherapy","authors":"M. Avila, D. Belfort, S. Martins, L. Hajjar","doi":"10.36660/abchf.20220078","DOIUrl":"https://doi.org/10.36660/abchf.20220078","url":null,"abstract":"injury. 6 Additionally, anthracyclines bind with iron, also leading to ROS production. 7 Anthracyclines cardiotoxicity usually leads to irreversible cardiomyocyte death. The mechanism of trastuzumab cardiotoxicity is not completely clear, but it is believed that blocking human epidermal growth factor receptor 2 (HER2) leads to growth factor dysregulation, affecting cardiomyocyte growth and homeostasis. 8 However, they rarely lead to cellular death, which partially explains the reversibility of myocardial injury caused by trastuzumab.","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126287201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Failure with Improved Ejection Fraction 心力衰竭伴射血分数提高
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20220067
Antonio Carlos Pereira Barretto
{"title":"Heart Failure with Improved Ejection Fraction","authors":"Antonio Carlos Pereira Barretto","doi":"10.36660/abchf.20220067","DOIUrl":"https://doi.org/10.36660/abchf.20220067","url":null,"abstract":"","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134402321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Age with Optimal Medical Therapy in Patients with Chronic Heart Failure 慢性心力衰竭患者年龄与最佳药物治疗的关系
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20220050
Vitoria A. A. Koga, Luiza Dall’Asta, Thiago L. P. Jacyntho, Leonardo C. De-Marchi, Rodrigo P. Mulinari, Bruna A. Ladeira, M. Németh, O. Silvestre, M. Bonatto, Lídia Ana Zytynski Moura, M. M. Fernandes-Silva
{"title":"Association of Age with Optimal Medical Therapy in Patients with Chronic Heart Failure","authors":"Vitoria A. A. Koga, Luiza Dall’Asta, Thiago L. P. Jacyntho, Leonardo C. De-Marchi, Rodrigo P. Mulinari, Bruna A. Ladeira, M. Németh, O. Silvestre, M. Bonatto, Lídia Ana Zytynski Moura, M. M. Fernandes-Silva","doi":"10.36660/abchf.20220050","DOIUrl":"https://doi.org/10.36660/abchf.20220050","url":null,"abstract":"","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132459350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstructive Cardiac Tumors 梗阻性心脏肿瘤
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20230001
S. Cauduro, João Pedro Passos Dutra, F. Fernandes, M. Bonatto, Maria Verônica Câmara Santos, Leticia dos Santos Araujo Rocha, Talita Ribeiro Mialski, Ana Moema Pereira Da Nóbrega, S. Brandão, S. Barberato
{"title":"Obstructive Cardiac Tumors","authors":"S. Cauduro, João Pedro Passos Dutra, F. Fernandes, M. Bonatto, Maria Verônica Câmara Santos, Leticia dos Santos Araujo Rocha, Talita Ribeiro Mialski, Ana Moema Pereira Da Nóbrega, S. Brandão, S. Barberato","doi":"10.36660/abchf.20230001","DOIUrl":"https://doi.org/10.36660/abchf.20230001","url":null,"abstract":"Cardiac tumors are considered rare clinical entities and can affect any cardiac tissue. Metastatic (secondary) cardiac tumors are more frequently diagnosed than primary tumors (malignant or benign). Both types can cause valve and/or inflow and outflow tract obstructions in any cardiac chamber, leading to symptoms of heart failure, as well as embolization and arrhythmia. Treatment of benign tumors is usually surgical, and that of metastatic and primary malignant tumors will depend on their origin and type, with poor prognosis. Recurrence of benign tumors is frequent. The aim of this article is to provide the clinician with tools to optimize diagnosis, differential diagnosis, and treatment of tumors with obstructive features causing heart failure.","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133312185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Reasoning and Classification of Cardiomyopathies 心肌病的临床原因及分型
ABC: Heart Failure &amp; Cardiomyopathy Pub Date : 1900-01-01 DOI: 10.36660/abchf.20230013
Vagner Madrini, E. T. Mesquita, D. Ávila, F. Fernandes
{"title":"Clinical Reasoning and Classification of Cardiomyopathies","authors":"Vagner Madrini, E. T. Mesquita, D. Ávila, F. Fernandes","doi":"10.36660/abchf.20230013","DOIUrl":"https://doi.org/10.36660/abchf.20230013","url":null,"abstract":"Clinical Reasoning and Classification of Cardiomyopathies Vagner Madrini Junior,1,2 Evandro Tinoco Mesquita,3 Diane Xavier de Avila,4,5 Fabio Fernandes1 Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo,1 São Paulo, SP – Brazil Hospital Israelita Albert Einstein,2 São Paulo – SP – Brazil Universidade Federal Fluminense Hospital Universitário Antônio Pedro,3 Niterói, RJ – Brazil Complexo Hospitalar de Niterói,4 Niterói, RJ – Brazil Universidade Federal Fluminense – Pós-graduação Ciências Cardiovasculares,5 Niterói, RJ – Brazil","PeriodicalId":328286,"journal":{"name":"ABC: Heart Failure &amp; Cardiomyopathy","volume":"2014 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116961960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书